Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 21;13(4):e14600.
doi: 10.7759/cureus.14600.

A Review of Alternative Treatment Options in Diabetic Polyneuropathy

Arsalan Zaheer  1 , Faizan Zaheer  2 , Hadia Saeed  1 , Zoya Tahir  3 , Muhammad Waqas Tahir  4
Affiliations
Review

A Review of Alternative Treatment Options in Diabetic Polyneuropathy

Arsalan Zaheer et al. Cureus. .

Abstract

Currently there is no recognized curative treatment for diabetic polyneuropathy (DPN). Strict glucose control and symptomatic pain relief are the first line management routes. DPN is a common complication of diabetes and has a major detrimental influence on the quality of life (QOL) for many patients. Due to the scope of the problem, it is imperative that treatment options which impede DPN's progression and restore sensorineural function should be researched comprehensively and made available to the masses at an economical cost. We reviewed a multitude of atypical treatment options for DPN including capsaicin, lidocaine, acupuncture, electrical nerve stimulation, alpha lipoic acid, benfotiamine, and acetyl-l-carnitine and explored the evidence to date regarding their safety and efficacy. Most of these options have been around for a long time and have promising pilot studies or small-scale trials focused on DPN treatment.

Keywords: diabetes; diabetic polyneuropathy; natural supplements; non-pharmacological treatments.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

Cited by

References

    1. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Zheng Y, Ley SH, Hu FB. Nat Rev Endocrinol. 2018;14:88–98. - PubMed
    1. Viral infections in type 1 diabetes mellitus - why the β cells? de Beeck AO, Eizirik DL. Nat Rev Endocrinol. 2016;12:263–273. - PMC - PubMed
    1. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Kahn SE, Cooper ME, Del Prato S. Lancet. 2014;383:1068–1083. - PMC - PubMed
    1. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Hicks CW, Selvin E. Curr Diab Rep. 2019;19:86. - PMC - PubMed
    1. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Curr Clin Pharmacol. 2011;6:260–273. - PMC - PubMed

LinkOut - more resources